Atlas Trials

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Clinical trial NCT04224571 · COMPLETED

Trial details

NCT number
NCT04224571
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia, in Relapse
Start date
2018-09-14
Primary completion
2023-02-15
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.